| Product NDC: | 67457-211 |
| Proprietary Name: | Fomepizole |
| Non Proprietary Name: | Fomepizole |
| Active Ingredient(s): | 1 g/mL & nbsp; Fomepizole |
| Administration Route(s): | INTRAVENOUS |
| Dosage Form(s): | INJECTION, SOLUTION |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 67457-211 |
| Labeler Name: | Mylan Institutional LLC |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA078639 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20121009 |
| Package NDC: | 67457-211-02 |
| Package Description: | 1 VIAL, GLASS in 1 CARTON (67457-211-02) > 1.5 mL in 1 VIAL, GLASS |
| NDC Code | 67457-211-02 |
| Proprietary Name | Fomepizole |
| Package Description | 1 VIAL, GLASS in 1 CARTON (67457-211-02) > 1.5 mL in 1 VIAL, GLASS |
| Product NDC | 67457-211 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Fomepizole |
| Dosage Form Name | INJECTION, SOLUTION |
| Route Name | INTRAVENOUS |
| Start Marketing Date | 20121009 |
| Marketing Category Name | ANDA |
| Labeler Name | Mylan Institutional LLC |
| Substance Name | FOMEPIZOLE |
| Strength Number | 1 |
| Strength Unit | g/mL |
| Pharmaceutical Classes | Antidote [EPC] |